PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
NUVL vs. EQT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between NUVL and EQT is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

NUVL vs. EQT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Nuvalent, Inc. (NUVL) and EQT Corporation (EQT). The values are adjusted to include any dividend payments, if applicable.

100.00%200.00%300.00%400.00%500.00%SeptemberOctoberNovemberDecember2025February
356.96%
187.85%
NUVL
EQT

Key characteristics

Sharpe Ratio

NUVL:

0.16

EQT:

1.50

Sortino Ratio

NUVL:

0.67

EQT:

2.17

Omega Ratio

NUVL:

1.08

EQT:

1.28

Calmar Ratio

NUVL:

0.22

EQT:

1.12

Martin Ratio

NUVL:

0.45

EQT:

4.71

Ulcer Index

NUVL:

17.76%

EQT:

11.05%

Daily Std Dev

NUVL:

51.12%

EQT:

34.75%

Max Drawdown

NUVL:

-80.70%

EQT:

-91.57%

Current Drawdown

NUVL:

-23.62%

EQT:

-8.54%

Fundamentals

Market Cap

NUVL:

$6.16B

EQT:

$30.69B

EPS

NUVL:

-$3.45

EQT:

$0.75

Total Revenue (TTM)

NUVL:

$0.00

EQT:

$3.41B

EBITDA (TTM)

NUVL:

-$194.07M

EQT:

$1.50B

Returns By Period

In the year-to-date period, NUVL achieves a 9.45% return, which is significantly lower than EQT's 10.84% return.


NUVL

YTD

9.45%

1M

9.50%

6M

22.42%

1Y

6.33%

5Y*

N/A

10Y*

N/A

EQT

YTD

10.84%

1M

4.31%

6M

65.04%

1Y

49.76%

5Y*

59.32%

10Y*

2.07%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

NUVL vs. EQT — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NUVL
The Risk-Adjusted Performance Rank of NUVL is 5151
Overall Rank
The Sharpe Ratio Rank of NUVL is 5252
Sharpe Ratio Rank
The Sortino Ratio Rank of NUVL is 5050
Sortino Ratio Rank
The Omega Ratio Rank of NUVL is 4848
Omega Ratio Rank
The Calmar Ratio Rank of NUVL is 5656
Calmar Ratio Rank
The Martin Ratio Rank of NUVL is 5151
Martin Ratio Rank

EQT
The Risk-Adjusted Performance Rank of EQT is 8282
Overall Rank
The Sharpe Ratio Rank of EQT is 8686
Sharpe Ratio Rank
The Sortino Ratio Rank of EQT is 8282
Sortino Ratio Rank
The Omega Ratio Rank of EQT is 8080
Omega Ratio Rank
The Calmar Ratio Rank of EQT is 8181
Calmar Ratio Rank
The Martin Ratio Rank of EQT is 7979
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

NUVL vs. EQT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Nuvalent, Inc. (NUVL) and EQT Corporation (EQT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for NUVL, currently valued at 0.16, compared to the broader market-2.000.002.004.000.161.50
The chart of Sortino ratio for NUVL, currently valued at 0.67, compared to the broader market-4.00-2.000.002.004.000.672.17
The chart of Omega ratio for NUVL, currently valued at 1.08, compared to the broader market0.501.001.502.001.081.28
The chart of Calmar ratio for NUVL, currently valued at 0.22, compared to the broader market0.002.004.006.000.221.35
The chart of Martin ratio for NUVL, currently valued at 0.45, compared to the broader market-30.00-20.00-10.000.0010.0020.0030.000.454.71
NUVL
EQT

The current NUVL Sharpe Ratio is 0.16, which is lower than the EQT Sharpe Ratio of 1.50. The chart below compares the historical Sharpe Ratios of NUVL and EQT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.502.002.50SeptemberOctoberNovemberDecember2025February
0.16
1.50
NUVL
EQT

Dividends

NUVL vs. EQT - Dividend Comparison

NUVL has not paid dividends to shareholders, while EQT's dividend yield for the trailing twelve months is around 1.25%.


TTM20242023202220212020201920182017201620152014
NUVL
Nuvalent, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EQT
EQT Corporation
1.25%1.39%1.58%1.66%0.00%0.24%1.10%83.85%0.00%0.00%0.00%0.00%

Drawdowns

NUVL vs. EQT - Drawdown Comparison

The maximum NUVL drawdown since its inception was -80.70%, smaller than the maximum EQT drawdown of -91.57%. Use the drawdown chart below to compare losses from any high point for NUVL and EQT. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-23.62%
-4.96%
NUVL
EQT

Volatility

NUVL vs. EQT - Volatility Comparison

Nuvalent, Inc. (NUVL) and EQT Corporation (EQT) have volatilities of 13.75% and 13.15%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%SeptemberOctoberNovemberDecember2025February
13.75%
13.15%
NUVL
EQT

Financials

NUVL vs. EQT - Financials Comparison

This section allows you to compare key financial metrics between Nuvalent, Inc. and EQT Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab